A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis

Increasing antimicrobial resistance among uropathogens limits treatment options for patients with complicated urinary tract infection (cUTI). Plazomicin, a new aminoglycoside, has in vitro activity against multidrug-resistant Enterobacteriaceae, including isolates resistant to currently available am...

Descripción completa

Detalles Bibliográficos
Autores principales: Connolly, Lynn E., Riddle, Valerie, Cebrik, Deborah, Armstrong, Eliana S., Miller, Loren G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913993/
https://www.ncbi.nlm.nih.gov/pubmed/29378708
http://dx.doi.org/10.1128/AAC.01989-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913993/
https://www.ncbi.nlm.nih.gov/pubmed/29378708
http://dx.doi.org/10.1128/AAC.01989-17

Ejemplares similares